Clinical Trial

The PRECISION-T2D Study: Precision Nutrition Study for Type 2 Diabetes

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 13, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Food plays a crucial role in determining blood glucose levels, especially in people with type 2 diabetes. Precision nutrition, which involves individually tailored dietary interventions, can be a powerful tool in managing blood glucose levels in people with type 2 diabetes. Previous studies found that changes in gut microbiota resulted from the dietary intervention, such as plant-based diet, might subsequently lead to different glycemic responses, and then different health outcomes. In this study, the investigators will characterize the blood glucose dynamics and gut microbiota of individuals with type 2 diabetes. They aim to assess the influence of plant-based diet on gut microbiota; they will also investigate the influence of gut microbiota on glycemic responses. Additionally, a series of individual N-of-1 trails will be integrated to compare the effects of a white bread breakfast and a whole wheat bread breakfast on glucose metabolism at the individual level.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-05-30; most recent amendment 2025-06-10.
Status change: Not Yet Recruiting → Recruiting 2023-08-01
Trial Details
NCT Number NCT05885828
Lead Sponsor Westlake University
Collaborators: The Third People's Hospital of Hangzhou
Conditions Type 2 Diabetes
Enrollment 200 participants
Start Date 2023-07-17
Primary Completion 2025-12-31 (estimated)
Study Completion 2033-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-13